PDE3A and cancer: Lewis et al. demonstrate that DNMDP, a potent and selective inhibitor of phosphodiesterase (PDE) 3A and PDE3B, effectively eradicates cancer cells by facilitating interactions between PDE3A/B and SFLN12, a crucial protein in this context.